test

Nicholas Boston

@Highvista Strategies Llc

Latest period2024 - Q3ReportedManaged Assets$289.961MTotal holdings142
Assets growth rate5.92%Assets growth rate (2-Q avg)1.78%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Highvista Strategies Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 142 positions.

Assets under management

The assets under management (AUM) of Highvista Strategies Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 289.961M in assets, with a quarterly growth rate of 5.92% and a 2-quarter average growth rate of 1.78%. The portfolio is managed by Nicholas Boston, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BBDBanco Bradesco S A
Recent Activity
Increased 9%
0.54%
$1.557M
585,400 shares@ $2.66 avg price
CRBPCorbus Pharmaceuticals Hldgs
Recent Activity
Increased 94.09%
0.54%
$1.553M
75,292 shares@ $20.64 avg price
ARVNArvinas Inc
Recent Activity
Increased 13.46%
0.5%
$1.429M
58,001 shares@ $24.64 avg price
NFLXNetflix Inc
Recent Activity
Increased 11.12%
0.49%
$1.419M
2,000 shares@ $709.27 avg price
PDDPdd Holdings Inc
Recent Activity
Increased 213.35%
0.38%
$1.089M
8,078 shares@ $134.81 avg price
JANXJanux Therapeutics Inc
Recent Activity
Increased 0.61%
0.37%
$1.066M
23,472 shares@ $45.44 avg price
APLSApellis Pharmaceuticals Inc
Recent Activity
Increased 375.49%
0.36%
$1.038M
35,975 shares@ $28.84 avg price
CRHCrh Plc
Recent Activity
Increased 9.91%
0.36%
$1.029M
11,100 shares@ $92.74 avg price
VERAVera Therapeutics Inc
Recent Activity
Increased 140.24%
0.34%
$972,842
22,010 shares@ $44.2 avg price
BEKEKe Hldgs Inc
Recent Activity
Increased 28.69%
0.21%
$607,394
30,507 shares@ $19.91 avg price